查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太心臟人工智慧监测与诊断市场：分析与预测（2023-2032）
市场调查报告书
商品编码
1421495

亚太心臟人工智慧监测与诊断市场：分析与预测（2023-2032）

Asia-Pacific Cardiac AI Monitoring and Diagnostics Market: Analysis and Forecast, 2023-2032
出版日期: | 出版商: BIS Research | 英文 135 Pages | 商品交期: 1-5个工作天内

价格

2023年亚太心臟人工智慧监测和诊断市场规模为2.004亿美元。

预计到 2032 年，市场规模将达到 21.546 亿美元，2023-2032 年预测期间复合年增长率为 30.20%。心血管疾病的流行、政府对医疗保健领域人工智慧的支持、心臟病学特定人工智慧研究的增加、人工智慧心臟设备的监管核准增加以及人工智慧心臟诊断技术推动了心臟人工智慧监测和诊断市场的增长。进步。

主要市场统计数据
预测期 2023-2032
2023年评估 2.004 亿美元
2032年预测 21.546 亿美元
复合年增长率 30.2%

由于几个关键因素，亚太心臟人工智慧监测和诊断市场正在显着成长。由于人口老化以及糖尿病和高血压等生活方式相关危险因子的流行，该地区面临心血管疾病的沉重负担。这增加了对先进诊断和监控工具的需求。亚太地区各国政府越来越认识到人工智慧在医疗保健领域的潜力，从而推出了对人工智慧技术的支持性政策和投资。此外，该地区正在见证医疗保健技术研究的激增，包括心臟病学中的人工智慧，使先进的诊断变得更加容易和高效。此外，监管部门对基于人工智慧的心臟诊断设备的核准数量不断增加，反映出人们对其有效性和安全性的信心不断增强。人工智慧的技术进步正在提高心臟诊断的精确度和准确度，以满足该地区多样化且不断增长的医疗保健需求。

该报告研究了亚太地区心臟人工智慧监测和诊断市场，提供了市场概述、按产品、类型、应用、最终用户、国家/地区以及参与市场的公司概况分類的趋势。

目录

执行摘要

第一章 市场

  • 市场展望

第二章 产业展望

  • 主要趋势
  • 机会评估
  • 法律规范
  • 专利分析
  • 经营模式
  • 案例研究
  • 正在进行的临床试验
  • 资金筹措场景
  • 最终使用者意识
  • 新参与企业的进入壁垒

第 3 章 COVID-19 的影响

第四章 区域

  • 亚太心臟人工智慧监测与诊断市场
    • 主要发现和机会评估
    • 数位化采用
    • 市场动态
    • 市场规模及预测

第五章市场－竞争基准化分析与公司概况

  • 心臟人工智慧监测和诊断领域活跃公司的生态系统
  • 关键策略和发展
    • 监管和法律活动
  • 公司简介
    • Canon Inc.
Product Code: BHD1841SS

“The Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Expected to Reach $2,154.6 Million by 2032.”

Introduction to Asia-Pacific Cardiac AI Monitoring and Diagnostics Market

The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2,154.6 million by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.

KEY MARKET STATISTICS
Forecast Period2023 - 2032
2023 Evaluation$200.4 Million
2032 Forecast$2,154.6 Million
CAGR30.2%

Market Introduction

The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology. Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.

Market Segmentation:

Segmentation 1: by Product

  • Software
  • Hardware

Segmentation 2: by Type

  • Cardiac Diagnostics
    • Imaging
    • ECG-Based
    • Others
  • Cardiac Monitoring

Segmentation 3: by Application

  • Ischemic Heart Disease/CAD
  • Cardiac Arrhythmias
  • Ischemic Stroke
  • Others

Segmentation 4: by End User

  • Hospitals
  • Diagnostic Centers
  • Other End Users

Segmentation 5: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Table of Contents

Executive Summary

1. Market

  • 1.1. Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion Criteria
    • 1.1.3. Exclusion Criteria
    • 1.1.4. Overview
      • 1.1.4.1. Market Size and Growth Potential

2. Industry Outlook

  • 2.1. Key Trends
    • 2.1.1. Rising Number of Startups in the Market
    • 2.1.2. Increased Awareness Regarding Preventative Measures and Personalized Treatment
    • 2.1.3. Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
  • 2.2. Opportunity Assessment
  • 2.3. Regulatory Framework
    • 2.3.1. Regulatory Framework for Artificial Intelligence-Based FDA-Approved Medical Devices and Algorithms
    • 2.3.2. Regulatory Framework in Japan
    • 2.3.3. Regulatory Framework in China
  • 2.4. Patent Analysis
    • 2.4.1. Awaited Technological Developments
      • 2.4.1.1. Patent Analysis (by Country)
      • 2.4.1.2. Patent Analysis (by Year)
  • 2.5. Business Models
  • 2.6. Case Studies
    • 2.6.1. Case Study 1: Ultromics Limited
      • 2.6.1.1. The EchoGo System
        • 2.6.1.1.1. Developement
        • 2.6.1.1.2. Use Case and Reliability
      • 2.6.1.2. A Success Story
      • 2.6.1.3. Partners and Recognitions
    • 2.6.2. Case Study 2: CorVista Health, Inc.
      • 2.6.2.1. The CorVista System
      • 2.6.2.2. A Success Story
  • 2.7. Ongoing Clinical Trials
  • 2.8. Funding Scenario
  • 2.9. End User Perception
  • 2.1. Entry Barriers for New Entrants

3. Impact of COVID-19

  • 3.1. Impact on the Overall Market
  • 3.2. Pre-COVID-19 Scenario
  • 3.3. During COVID-19 Scenario
  • 3.4. Post COVID-19 Scenario

4. Regions

  • 4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
    • 4.1.1. Key Findings and Opportunity Assessment
    • 4.1.2. Digital Adoption
    • 4.1.3. Market Dynamics
      • 4.1.3.1. Impact Analysis
    • 4.1.4. Market Sizing and Forecast
      • 4.1.4.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
      • 4.1.4.2. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
        • 4.1.4.2.1. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
      • 4.1.4.3. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
      • 4.1.4.4. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)
      • 4.1.4.5. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country)
        • 4.1.4.5.1. Japan
          • 4.1.4.5.1.1. Market Dynamics
          • 4.1.4.5.1.2. Market Size and Forecast
          • 4.1.4.5.1.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.1.2.2. Japan Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.1.2.2.1. Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.1.2.3. Japan Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.1.2.4. Japan Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.2. China
          • 4.1.4.5.2.1. Market Dynamics
          • 4.1.4.5.2.2. Market Size and Forecast
          • 4.1.4.5.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.2.2.2. China Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.2.2.2.1. China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.2.2.3. China Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.2.2.4. China Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.3. India
          • 4.1.4.5.3.1. Market Dynamics
          • 4.1.4.5.3.2. Market Size and Forecast
          • 4.1.4.5.3.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.3.2.2. India Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.3.2.2.1. India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.3.2.3. India Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.3.2.4. India Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.4. Australia
          • 4.1.4.5.4.1. Market Dynamics
          • 4.1.4.5.4.2. Market Size and Forecast
          • 4.1.4.5.4.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.4.2.2. Australia Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.4.2.2.1. Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.4.2.3. Australia Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.4.2.4. Australia Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.5. South Korea
          • 4.1.4.5.5.1. Market Dynamics
          • 4.1.4.5.5.2. Market Size and Forecast
          • 4.1.4.5.5.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.5.2.2. South Korea Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.5.2.2.1. South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.5.2.3. South Korea Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.5.2.4. South Korea Cardiac AI Monitoring and Diagnostics Market (by End User)
        • 4.1.4.5.6. Rest-of-Asia-Pacific
          • 4.1.4.5.6.1. Market Size and Forecast
          • 4.1.4.5.6.1.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product)
          • 4.1.4.5.6.1.2. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type)
          • 4.1.4.5.6.1.2.1. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics)
          • 4.1.4.5.6.1.3. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application)
          • 4.1.4.5.6.1.4. Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User)

5. Markets - Competitive Benchmarking & Company Profiles

  • 5.1. Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
  • 5.2. Key Strategies and Developments
    • 5.2.1. Regulatory and Legal Activities
  • 5.3. Company Profiles
    • 5.3.1. Canon Inc.
      • 5.3.1.1. Company Overview
      • 5.3.1.2. Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
      • 5.3.1.3. Financials
      • 5.3.1.4. Analyst Perception

List of Figures

  • Figure 1: AI in Cardiac Monitoring and Diagnosis
  • Figure 2: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 3: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Market Dynamics
  • Figure 4: Key Trends in the Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
  • Figure 5: Entry Barriers for New Entrants
  • Figure 6: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Product), 2022 and 2032
  • Figure 7: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Type), 2022 and 2032
  • Figure 8: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by Application), 2022 and 2032
  • Figure 9: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Share (by End Users), 2022 and 2032
  • Figure 10: Key Developments and Strategies Analysis, January 2020-June 2023
  • Figure 11: Cardiac AI Monitoring and Diagnostics Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Overview of the Role of AI in Cardiology
  • Figure 16: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Size and Growth Potential, $Million, 2022-2032
  • Figure 17: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Key Trends
  • Figure 18: Potential of AI for Processing Patient's Own Data
  • Figure 19: Advantages of AI-Enabled Wearable Sensors for Cardiac Monitoring
  • Figure 20: Cardiac AI Monitoring and Diagnostics Market, Key Trends, Opportunity Assessment, 2023-2032
  • Figure 21: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Country), January 2018-June 2023
  • Figure 22: Cardiac AI Monitoring and Diagnostics Market, Patent Analysis (by Year), January 2018-June 2023
  • Figure 23: Different Types of Business Models in the AI in Healthcare Scenario
  • Figure 24: Subscription-Based Model the Market is Shifting Towards
  • Figure 25: Partners of Ultromics Limited
  • Figure 26: Ultromics Limited:Awards and Recognitions
  • Figure 27: The CorVista System
  • Figure 28: Cardiac AI Monitoring and Diagnostics Market, Quarterly Analysis of Funding Scenario, January 2020-June 2023
  • Figure 29: Cardiac AI Monitoring and Diagnostics Market, End User Perceptions
  • Figure 30: Entry Barriers for New Entrants
  • Figure 31: Recommendations to Tackle the Entry Barriers
  • Figure 32: Tools and Technologies of AI for Cardiology During COVID-19
  • Figure 33: Cardiac AI Monitoring and Diagnostics Market Share (by Region), 2022-2032
  • Figure 34: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Incremental Opportunity (by Country), $Million, 2023-2032
  • Figure 35: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 36: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 37: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 38: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 39: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 40: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 41: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Country), % Share, 2022 and 2032
  • Figure 42: Japan Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 43: Japan Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 44: Japan Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 45: Japan Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 46: Japan Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 47: Japan Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 48: China Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 49: China Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 50: China Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 51: China Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 52: China Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 53: China Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 54: India Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 55: India Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 56: India Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 57: India Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 58: India Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 59: India Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 60: Australia Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 61: Australia Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 62: Australia Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 63: Australia Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 64: Australia Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 65: Australia Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 66: South Korea Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 67: South Korea Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 68: South Korea Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 69: South Korea Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 70: South Korea Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 71: South Korea Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 72: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, $Million, 2022-2032
  • Figure 73: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Product), $Million, 2022-2032
  • Figure 74: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Type), $Million, 2022-2032
  • Figure 75: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Cardiac Diagnostics), $Million, 2022-2032
  • Figure 76: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by Application), $Million, 2022-2032
  • Figure 77: Rest-of-Asia-Pacific Cardiac AI Monitoring and Diagnostics Market (by End User), $Million, 2022-2032
  • Figure 78: Share of Key Developments and Strategies, January 2019-June 2023
  • Figure 79: Regulatory and Legal Activities (by Company), January 2019-June 2023
  • Figure 80: Canon Inc.: Overall Product Portfolio
  • Figure 81: Canon Inc.: Overall Financials, $Million, 2020-2022
  • Figure 82: Canon Inc.: Net Revenue (by Segment), $Million, 2020-2021
  • Figure 83: Canon Inc.: Net Revenue (by Segment), $Million, 2022
  • Figure 84: Canon Inc.: Net Revenue (by Region), $Million, 2020-2022
  • Figure 85: Canon Inc.: R&D Expenditure, $Million, 2020-2022

List of Tables

  • Table 1: Regulatory Framework
  • Table 2: Key Questions Answered in the Report
  • Table 3: Startups Entering the Market
  • Table 4: Regulatory Framework of Different Countries
  • Table 5: Cardiac AI Monitoring and Diagnostics Market, Awaited Technological Developments
  • Table 6: CorVista Health Inc. Publications
  • Table 7: Cardiac AI Monitoring and Diagnostics Market, Ongoing Clinical Trials
  • Table 8: Investments and Fundings in Cardiac AI Monitoring and Diagnostics Market
  • Table 9: Applications of Artificial Intelligence in Cardiology During COVID-19 Pandemic
  • Table 10: Asia-Pacific Cardiac AI Monitoring and Diagnostics Market, Impact Analysis
  • Table 11: Total Deaths and CVD Death Rates of Men/Women in 2018 in Japan (Per 100,000 of the Population)
  • Table 12: Cardiac AI Monitoring and Diagnostics Active Players Ecosystem